微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.08% | 22.52% | -71.59% | 17/158 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 14.36% | 35.73% | 31.99% | 14/158 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 10.88% | 22.11% | 31.72% | 21/158 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 8.26% | 43.15% | 148.05% | 16/158 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 3.33% | 3.1% | -68.53% | 24/158 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 10.58% | 11.25% | 18.74% | 28/158 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.91% | 0.34% | 54.42% | 31/158 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 5.77% | 3.59% | 78.64% | 30/158 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.23% | -6.92% | -66.04% | 31/158 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 9.51% | -26.51% | 7.09% | 45/158 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 8.88% | -31.48% | 59.43% | 36/158 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 5.57% | -32.65% | 60.52% | 42/158 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 3.47% | -27.41% | -73.18% | 26/158 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 12.94% | -38.96% | -0.15% | 30/158 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 12.96% | -19.2% | 56.71% | 15/158 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 8.27% | -16.04% | 73.01% | 24/158 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 4.78% | -7.54% | -77.45% | 15/158 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 21.2% | -5.53% | 32.17% | 18/158 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 16.04% | -6.42% | 62.84% | 13/158 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 9.85% | -9.22% | 90.52% | 20/158 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 5.17% | -11.93% | -76.96% | 10/158 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 22.44% | 1.68% | 30.92% | 15/158 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 17.14% | -0.52% | 57.97% | 9/158 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 10.85% | -2.86% | 84.84% | 11/158 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 5.87% | -2% | -73.4% | 9/158 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 22.07% | -1.69% | 28.09% | 11/158 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 17.23% | -0.63% | 54.25% | 4/158 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 11.17% | -5.26% | 86.48% | 8/158 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 5.99% | -5.67% | -73.32% | 8/158 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 22.45% | -3.44% | 29.47% | 8/158 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 17.34% | -2.58% | 47.07% | 8/158 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 11.79% | -5.3% | 85.67% | 8/158 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 6.35% | -4.65% | -72.69% | 5/158 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 23.25% | -4.56% | 30.62% | 14/158 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 17.8% | -1.17% | 42.97% | 8/158 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 12.45% | -1.03% | 86.94% | 5/158 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 6.66% | -0.15% | -72.66% | 6/158 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 24.36% | 14.91% | 35.26% | 16/158 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 18.01% | 11.31% | 43.16% | 8/158 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 12.58% | 11.62% | 88.61% | 10/158 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 6.67% | 11.91% | -68.54% | 6/158 | 2.41% | 华东医药 | 26.63% | 行业排名> |